InsidersTradesSigma
Follow the NAN share price and the full insider trade history of the company, a publicly traded company based in Australia. Shares are listed on the AU market, under the authority of ASX. Operating in the Health Care sector, NAN has published 5 public disclosures. Market capitalisation: €798.1m. The latest transaction was filed on 28 August 2026 (Purchase). Among the most active insiders: 2. Details of voting power. All data is free.
5
Insider Decl.
n/a
Thresholds
€17,652
1 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate NAN Buy (bullish), based on 8 analysts. Average price target: A$3.92.
Fundamental score
Ranked 13,477 of 29,056 companies
53.9
score / 100
Value37
Quality71
FCF yld2.2%
Earn yld2.2%
EV/EBITDA27.2x
ROE8.3%
Gross mgn77%
Net mgn8.7%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 August 2026
Declarations5 total
10,000 shares@ A$2.87ShareASXASX:2924-03128304-2A1693236
ShareASXASX:2924-03094961-2A1674400
ShareASXASX:2924-03089787-2A1671937
ShareASXASX:2924-03089364-2A1671731
ShareASXASX:2924-03088867-2A1671500
5 of 5 declarations
Acerca de NAN
NAN es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el XASX. Se enfoca en desarrollar soluciones innovadoras para mejorar la salud del paciente.
